Q&A

Jessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.

by Marci A. Landsmann

Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.

by Sandra Gordon

Study suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.

by Jon Kelvey

Black men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.

by Kyle Bagenstose

Researchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.

by Sandra Gordon

Experts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.

by Kyle Bagenstose

New treatments aim to lengthen remissions and push back recurrences.

by Erin O’Donnell

Survivor Profile

Former teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.

by Kristin Baird Rattini

Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.

by Kendall K. Morgan

Forward Look

Hematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.

by Ashley P. Taylor